[HTML][HTML] Patient-derived organoids in translational oncology and drug screening

R Yang, Y Yu - Cancer Letters, 2023‏ - Elsevier
Patient-derived organoids (PDO) are a new biomedical research model that can reconstruct
phenotypic and genetic characteristics of the original tissue and are useful for research on …

Gastric cancer

E Van Cutsem, X Sagaert, B Topal, K Haustermans… - The Lancet, 2016‏ - thelancet.com
Gastric cancer is one of the leading causes of cancer-related death worldwide. Many
patients have inoperable disease at diagnosis or have recurrent disease after resection with …

Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up

L Yan, Y Chen, F Chen, T Tao, Z Hu, J Wang, J You… - Gastroenterology, 2022‏ - Elsevier
Background & Aims Helicobacter pylori infection is considered as the most important risk
factor in the pathogenesis of gastric cancer. This study aims to evaluate the long-term effects …

Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus

JM Liou, P Malfertheiner, YC Lee, BS Sheu, K Sugano… - Gut, 2020‏ - gut.bmj.com
Objective A global consensus meeting was held to review current evidence and knowledge
gaps and propose collaborative studies on population-wide screening and eradication of …

British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma

M Banks, D Graham, M Jansen, T Gotoda, S Coda… - Gut, 2019‏ - gut.bmj.com
Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis.
Risk factors include Helicobacter pylori infection, family history of gastric cancer—in …

Family History of Gastric Cancer and Helicobacter pylori Treatment

IJ Choi, CG Kim, JY Lee, YI Kim, MC Kook… - … England Journal of …, 2020‏ - Mass Medical Soc
Background Helicobacter pylori infection and a family history of gastric cancer are the main
risk factors for gastric cancer. Whether treatment to eradicate H. pylori can reduce the risk of …

Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention

C Tomasetti, L Li, B Vogelstein - Science, 2017‏ - science.org
Cancers are caused by mutations that may be inherited, induced by environmental factors,
or result from DNA replication errors (R). We studied the relationship between the number of …

Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial

KF Pan, WQ Li, L Zhang, WD Liu, JL Ma, Y Zhang… - Nature medicine, 2024‏ - nature.com
Gastric cancer is a leading cause of cancer-related deaths in China. Affecting more than
40% of the world's population, Helicobacter pylori is a major risk factor for gastric cancer …

Diallyl disulfide: a bioactive garlic compound with anticancer potential

S Mitra, R Das, TB Emran, RK Labib, F Islam… - Frontiers in …, 2022‏ - frontiersin.org
Cancer is a life-threatening disease caused by the uncontrolled division of cells, which
culminates in a solid mass of cells known as a tumor or liquid cancer. It is the leading cause …

Gastric cancer: Epidemiology, risk factors and prevention strategies

L Yang, X Ying, S Liu, G Lyu, Z Xu… - Chinese Journal of …, 2020‏ - pmc.ncbi.nlm.nih.gov
Gastric cancer (GC) is a global health problem, with more than 1 million people newly
diagnosed with GC worldwide each year. GC is more prevalent in less developed countries …